William David

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 607 citations · Full text

Medicine, Neurology, Pharmacology +17

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

Mamatha Pasnoor, Jianghua He, Ted M. Burns et al. · Neurology · 2016 · 131 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The ALSSQOL

Zachary Simmons, S. H. Felgoise, Barbara A. Bremer et al. · Neurology · 2006 · 128 citations

Social Sciences, Neurology, Behavioral Health +16

Randomized trial of <scp>l</scp> -serine in patients with hereditary sensory and autonomic neuropathy type 1

Vera Fridman, Saranya Suriyanarayanan, Péter Novák et al. · Neurology · 2019 · 115 citations · Full text

Medicine, Neurology, Pharmacotherapy +17